Gastroenterology@TUM
@GastroTUM
Translational Gastroenterology, Klinik für Innere Medizin II, TUM University Hospital Rechts der Isar Legal notice: https://www.med2.mri.tum.de/en/imprint.php
#Research #News: @MaxReichertMD, @arispapargyriou and colleagues from @TU_Muenchen have developed a new 3D culture system called “branched” #organoids - a better model to study #pancreaticcancer in vitro. ➔ Our #publication in @natBME: nature.com/articles/s4155… #PDAC #Munich
💗My new cover for @NatureBME: Branched #organoids uncover hidden diversity in cancer🦀 The cover illustrates diverse pancreatic cancer organoids. @MaxReichertMD, @arispapargyriou and colleagues from @TU_Muenchen have developed a new 3D culture system called “branched”…
Last reminder Today, 5pm, in #Munich & via Zoom: Lecture "Targeting #pancreaticcancer progression, metastasis and treatment resistance guided by intravital imaging" by Dr. David Herrmann, @GarvanInstitute. We will be happy to welcome you to this talk! med2.mri.tum.de/en/seminar_ser…
🤩Super excited our branched #PancreaticCancer #Organoids to capture tumour heterogeneity made it on the cover of @natBME 🙏🏼nature.com/natbiomedeng/v… @TU_Muenchen @DKTK_ @TUMKlinikum @arispapargyriou @LabReichert
What a great day! 😁 Very happy to see the latest cover of @natBME featuring our paper from my PhD work with @MaxReichertMD @TU_Muenchen on #Organoids capturing tumour heterogeneity!! Thanks to an amazing team! 🤩 Thanks to @Ella_Maru for the cover ☺️! nature.com/articles/s4155…
🤩Super excited our branched #PancreaticCancer #Organoids to capture tumour heterogeneity made it on the cover of @natBME 🙏🏼nature.com/natbiomedeng/v… @TU_Muenchen @DKTK_ @TUMKlinikum @arispapargyriou @LabReichert
"#COVID-19 Disease Burden in the Omicron Variant-Dominated Endemic Phase: Insights from the #ROUTINE-COV19 Study Using Real-World German Statutory Health Insurance Data" - check out our #publication in #Viruses. pubmed.ncbi.nlm.nih.gov/40143351/ @NCBI @TU_Muenchen #Research #Munich
